Effects of Pelvic Exercises on Birth and Incontinence

NCT07268014 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 151

Last updated 2025-12-15

No results posted yet for this study

Summary

The Effect of Pelvic Floor Exercises During Pregnancy on Obstetric Outcomes and Urinary Incontinence: A Prospective Randomized Controlled Trial

Conditions

  • Maternal-Fetal Relations
  • Birth, First
  • Incontinence, Urinary
  • Pelvic Floor Disorders

Interventions

OTHER

Pelvic Exercise Group

Pregnant women in the exercise group will participate in an eight-week pelvic floor exercise program. The program begins with a face-to-face group training session during a childbirth preparation class at Konya City Hospital, in groups of 15, led by a midwife. Training covers pelvic floor anatomy, correct muscle identification, Kegel exercises, breathing, relaxation techniques, and exercise demonstrations. Following the session, participants will perform exercises three times a week for eight weeks, including Kegels, breathing-coordinated contractions, pelvic floor exercises in various positions, core stabilization exercises, and integration into daily activities. Weekly video materials will support proper exercise and motivation, and participants will record their practice in an exercise diary. At the end, experiences will be evaluated, and guidance for postpartum continuation will be provided.

Sponsors & Collaborators

  • Selcuk University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2026-06-01
Completion
2026-06-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07268014 on ClinicalTrials.gov